AUXL Insider Trading Activity and SEC Form 4 Filings
AUXL insider trading summary
No open-market insider purchases or sales of Auxilium Pharmaceuticals Inc (AUXL) have been reported on SEC Form 4 in the past 12 months.
Latest AUXL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 5, 2014 | Nancy Lurker | Director | Sell | $850K (25,000 @ $34.00) |
| Dec 5, 2014 | Paul A Friedman | Director | Sell | $328K (9,689 @ $33.85) |
| Dec 5, 2014 | Adrian Adams | CEO and President | Sell | $1.4M (40,000 @ $33.97) |
| Dec 5, 2014 | Nancy Lurker | Director | Sell | $253K (7,430 @ $34.00) |
| Dec 5, 2014 | William McKee | Director | Sell | $612K (18,000 @ $34.00) |
| Dec 4, 2014 | Paul A Friedman | Director | Sell | $673K (20,000 @ $33.67) |
| Dec 3, 2014 | Oliver Fetzer | Director | Sell | $1.7M (50,000 @ $34.00) |
| Dec 2, 2014 | Rolf A Classon | Director | Sell | $646K (19,135 @ $33.75) |
| Dec 2, 2014 | Oliver Fetzer | Director | Sell | $1.7M (50,000 @ $34.03) |
| Dec 2, 2014 | Rolf A Classon | Director | Sell | $8.8M (260,000 @ $33.81) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.